ANABIOTICASubmit a source
Supplements

Coenzyme Q10

A mitochondrial cofactor with a possible adjunctive role in heart failure, but inconsistent evidence for common wellness and statin-muscle claims.

Emerging
Evidence rating
Evidence review

What the evidence says

Coenzyme Q10 is involved in mitochondrial energy transfer and is sold as ubiquinone or ubiquinol. The clinically interesting evidence is not generic energy enhancement but adjunctive use in chronic heart failure, where a Cochrane review found possible reductions in hospitalization and mortality while stressing small studies, heterogeneity, and unclear or high risk of bias.[2][1]

Q-SYMBIO randomized 420 patients with moderate-to-severe heart failure to 300 mg daily or placebo for two years. Major cardiovascular events occurred in 15% versus 26%, but short-term functional endpoints did not improve and this single modest-sized trial heavily influences pooled clinical outcomes.[3]

A 2024 meta-analysis of 33 heart-failure trials also reported lower mortality and hospitalization, yet formulation, dose, background therapy, trial quality, and publication settings varied. CoQ10 should therefore be considered only as a clinician-reviewed adjunct, never a replacement for guideline-directed heart-failure treatment.[4][2]

The popular claim that CoQ10 reliably prevents statin-associated muscle pain is not supported by a placebo-controlled meta-analysis. NCCIH describes mostly mild insomnia or gastrointestinal symptoms but notes possible interactions with warfarin, insulin, and some cancer treatments.[5][1]

Potential benefits

  • May reduce heart-failure hospitalization when added to standard therapy, although confirmation is needed.[2][4]
  • May reduce mortality in selected chronic heart-failure populations, based largely on limited trial evidence.[3][2]

Side effects and cautions

  • Can cause mild insomnia, nausea, diarrhea, appetite loss, or abdominal discomfort.[1]
  • May interact with warfarin, insulin, and some cancer therapies.[1]
How we scored it

Evidence breakdown

Heart-failure analyses suggest fewer hospitalizations and possibly deaths, largely influenced by a small number of trials; evidence for statin muscle symptoms and general prevention is unconvincing.

Clinical relevanceHigh

Heart-failure studies include hospitalization and mortality, not only biomarkers.

Study qualityLow

Small heterogeneous trials and risk-of-bias concerns make the apparently important effects uncertain.

Safety dataModerate

Short-term tolerability is generally good, with interaction and long-term-data limitations.

References

Full source list

  1. Coenzyme Q10

    National Center for Complementary and Integrative Health · 2025

  2. Coenzyme Q10 for heart failure

    Cochrane Database of Systematic Reviews · 2021

  3. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO

    JACC: Heart Failure · 2014

  4. Efficacy and safety of coenzyme Q10 in heart failure: a meta-analysis of randomized controlled trials

    BMC Cardiovascular Disorders · 2024

  5. Effects of coenzyme Q10 supplementation on statin-induced myopathy: a meta-analysis of randomized controlled trials

    Atherosclerosis · 2020